Drug Search Results
More Filters [+]

Relenopride

Alternative Names: relenopride, ykp10811
Latest Update: 2015-06-12
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: 5-HT4 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: SK Life Science
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Relenopride

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Constipation|Irritable Bowel Syndrome

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

YKP

P2

Completed

Constipation|Irritable Bowel Syndrome

2014-12-01

YKP10811C006

P2

Completed

Constipation

2014-09-01

YKP10811C003

P2

Completed

Constipation

2013-11-01

Recent News Events

Date

Type

Title